ARTICLE | Clinical News
LXN regulatory update
December 15, 1997 8:00 AM UTC
LXN received U.S. Patent No. 5,695,949 for its Duet glucose control monitoring system that uses fingerstick tests to measure both blood glucose and glycated protein in diabetics. ...